44 2033180199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Heart Research

Sign up for email alert when new content gets added: Sign up

Short assessment on cell-based therapies

Author(s): Hazel Stewart*

Globally, Congestive Heart Failure (CHF) caused by chronic coronary artery disease is a leading cause of morbidity and mortality. Despite breakthroughs in medical and device therapy, its prevalence is rising. Adult stem cell therapies have emerged as a viable treatment for creating new cardio-myocytes and arteries, and they are expected to reverse functional decline in patients with congestive heart failure who are not candidates for heart transplantation. The greatest favorable outcomes from cell therapy are related with paracrine actions rather than direct differentiation, according to research conducted over the last two decades. Paracrine substances produced by stem cells, such as growth factors, cytokines, and microRNAs reduce scar volume and myocyte apoptosis, boost myocyte proliferation, and activate endogenous cardiac stem cells to create new myocytes.


Full-Text | PDF
 
Google Scholar citation report
Citations : 1023

Journal of Heart Research received 1023 citations as per Google Scholar report

pulsus-health-tech
Top